Clinical Trial Update: RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating RNA-lipid particle vaccines for recurrent or progressive medulloblastoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma

Drugs mentioned

• RNA-lipid Particle Vaccine (RNA-LP)

Snippet

Sponsor: University of Florida | Conditions: Recurrent Medulloblastoma | Phase 1 | Status: NOT_YET_RECRUITING